Confidentiality Notice
Regulatory Perspectives on Juvenile Animal Toxicologic Pathology - Deepa B. Rao, Alan M. Hoberman, Paul C. Brown, Aurore Varela, Brad Bolon, 2021
2022 Aetna Standard Plan (SI - 1500)
Osteoporosis and teriparatide
Descriptive statistics of serum and seminal fluid denosumab... | Download Table
208716Orig1s000
Australian public assessment report for denosumab
BeiGene, Ltd. 百濟神州有限公司
PDF) Predicting Nonlinear Changes in Bone Mineral Density Over Time Using a Multiscale Systems Pharmacology Model
Australian public assessment report for denosumab
CLINICAL OUTCOME ASSESSMENT (COA) COMPENDIUM
Molecules | Free Full-Text | Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis
Phytoconstituents as novel osteo-protective agents: Implications in bone health
Supplementary appendix
208743Orig1s000
Therapeuticmcq200
Australian public assessment report for denosumab
208743Orig1s000
Confidentiality Notice
Supplementary appendix
208743Orig1s000
